国产午夜福利片1000无码丨人妻国产成人久久av免费高清丨午夜做受视频试看6次丨日韩av不卡一区在线免费观看丨在线观看精品三级欧美

Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號 規(guī)格
Recombinant Dehalococcoides ethenogenes 3-isopropylmalate dehydrogenase (leuB) CSB-YP674695DAAI
CSB-EP674695DAAI
CSB-BP674695DAAI
CSB-MP674695DAAI
CSB-EP674695DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Adenine deaminase (ade), partial CSB-YP674696DAAI
CSB-EP674696DAAI
CSB-BP674696DAAI
CSB-MP674696DAAI
CSB-EP674696DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Threonine--tRNA ligase (thrS), partial CSB-YP674697DAAI
CSB-EP674697DAAI
CSB-BP674697DAAI
CSB-MP674697DAAI
CSB-EP674697DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Bifunctional protein FolD (folD1) CSB-YP674698DAAI
CSB-EP674698DAAI
CSB-BP674698DAAI
CSB-MP674698DAAI
CSB-EP674698DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Enolase (eno) CSB-YP674699DAAI
CSB-EP674699DAAI
CSB-BP674699DAAI
CSB-MP674699DAAI
CSB-EP674699DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes ATP synthase subunit beta (atpD) CSB-YP674700DAAI
CSB-EP674700DAAI
CSB-BP674700DAAI
CSB-MP674700DAAI
CSB-EP674700DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Methylthioribose-1-phosphate isomerase (mtnA) CSB-YP674701DAAI
CSB-EP674701DAAI
CSB-BP674701DAAI
CSB-MP674701DAAI
CSB-EP674701DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes 30S ribosomal protein S4 (rpsD) CSB-YP674702DAAI
CSB-EP674702DAAI
CSB-BP674702DAAI
CSB-MP674702DAAI
CSB-EP674702DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes 50S ribosomal protein L18 (rplR) CSB-YP674703DAAI
CSB-EP674703DAAI
CSB-BP674703DAAI
CSB-MP674703DAAI
CSB-EP674703DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes 30S ribosomal protein S19 (rpsS) CSB-YP674704DAAI
CSB-EP674704DAAI
CSB-BP674704DAAI
CSB-MP674704DAAI
CSB-EP674704DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes 30S ribosomal protein S12 (rpsL) CSB-YP674705DAAI
CSB-EP674705DAAI
CSB-BP674705DAAI
CSB-MP674705DAAI
CSB-EP674705DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Malate dehydrogenase (mdh) CSB-YP674706DAAI
CSB-EP674706DAAI
CSB-BP674706DAAI
CSB-MP674706DAAI
CSB-EP674706DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Valine--tRNA ligase (valS), partial CSB-YP674707DAAI
CSB-EP674707DAAI
CSB-BP674707DAAI
CSB-MP674707DAAI
CSB-EP674707DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes 30S ribosomal protein S2 (rpsB) CSB-YP674708DAAI
CSB-EP674708DAAI
CSB-BP674708DAAI
CSB-MP674708DAAI
CSB-EP674708DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Transcriptional repressor NrdR (nrdR) CSB-YP674709DAAI
CSB-EP674709DAAI
CSB-BP674709DAAI
CSB-MP674709DAAI
CSB-EP674709DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Phosphopantetheine adenylyltransferase (coaD) CSB-YP674710DAAI
CSB-EP674710DAAI
CSB-BP674710DAAI
CSB-MP674710DAAI
CSB-EP674710DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Alanine--tRNA ligase (alaS), partial CSB-YP674711DAAI
CSB-EP674711DAAI
CSB-BP674711DAAI
CSB-MP674711DAAI
CSB-EP674711DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Dehalococcoides ethenogenes Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP674712DAAI
CSB-EP674712DAAI
CSB-BP674712DAAI
CSB-MP674712DAAI
CSB-EP674712DAAI-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Rat Breast carcinoma-amplified sequence 1 homolog (Bcas1) CSB-YP674713RA
CSB-EP674713RA
CSB-BP674713RA
CSB-MP674713RA
CSB-EP674713RA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bovine AP-4 complex subunit sigma-1 (AP4S1) CSB-YP674714BO
CSB-EP674714BO
CSB-BP674714BO
CSB-MP674714BO
CSB-EP674714BO-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長度(全長或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://www.jhhuazhong.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>